PTO- 1478 |
Approved for use through 05/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90730802 |
Filing Date: 05/24/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90730802 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\907\308\90730802\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | TEVADAPTOR2 |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of word "TEVADAPTOR" in stylized capital letters with a small upside down "v" to the top right of the letter "R". The number "2" is to the right of the upside down "v". |
PIXEL COUNT ACCEPTABLE | NO |
PIXEL COUNT | 414 x 176 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Teva Pharmaceutical Industries Ltd. |
*MAILING ADDRESS | 400 Interpace Parkway |
*CITY | Parsippany |
*STATE (Required for U.S. applicants) |
New Jersey |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
07054 |
*DOMICILE | XXXX |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Israel |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 010 |
*IDENTIFICATION | Medical apparatus, namely, vial adaptors, bag adaptors, syringe adaptors, converters, connectors and parts and accessories therefor, for compounding and dispensing of pharmaceuticals to patients, namely, for introducing pharmaceutical preparations into the body of humans and animals |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Laurence Rickles |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
STREET | 400 Interpace Parkway |
CITY | Parsippany |
STATE | New Jersey |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 07054 |
EMAIL ADDRESS | Laurence.rickles@tevapharm.com |
CORRESPONDENCE INFORMATION | |
NAME | Laurence Rickles |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | Laurence.rickles@tevapharm.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | maureen.manson@tevapharm.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /laurencerickles/ |
SIGNATORY'S NAME | Laurence Rickles |
SIGNATORY'S POSITION | Attorney of Record, NY Bar |
DATE SIGNED | 05/24/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 05/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90730802 |
Filing Date: 05/24/2021 |
The applicant's current Correspondence Information: |
Laurence Rickles |
PRIMARY EMAIL FOR CORRESPONDENCE: Laurence.rickles@tevapharm.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): maureen.manson@tevapharm.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|